8.8699

0.58% 0.0799

CorMedix Inc (CRMD)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Forum Previsione Frazionamento azionario

Precedente Chiudi:

$8.79

Aprire:

$8.73

Volume 24 ore:

376.67K

Relative Volume:

0.29

Capitalizzazione di mercato:

$697.44M

Reddito:

$400.05M

Utile/perdita netta:

$181.01M

Rapporto P/E:

4.2252

EPS:

2.0993

Flusso di cassa netto:

$194.71M

1 W Prestazione:

+12.62%

1M Prestazione:

+5.75%

6M Prestazione:

-20.85%

1 anno Prestazione:

-22.59%

Intervallo 1D:

$8.61

$8.94

Intervallo di 1 settimana:

$7.98

$8.94

Portata 52W:

$6.125

$14.96

CorMedix Inc Stock (CRMD) Company Profile

Nome

CorMedix Inc

Settore

Healthcare (1100)

Industria

Biotechnology (615)

Telefono

908-517-9500

Indirizzo

400 Connell Drive, 5th Floor, Suite 5000, Berkeley Heights, NJ

Dipendente

Cinguettio

Prossima data di guadagno

2026-08-06

Ultimi documenti SEC

CRMD's Discussions on Twitter

Compare CRMD vs VRTX, REGN, ARGX, ALNY, RVMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
CRMD CorMedix Inc	8.89	686.45M	400.05M	181.01M	194.71M	2.0993
VRTX Vertex Pharmaceuticals Inc	525.47	134.02B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	670.90	68.59B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	926.20	58.44B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	317.14	41.76B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	190.90	40.23B	742.00K	-1.37B	-1.07B	-7.0731

CorMedix Inc Stock (CRMD) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-10-20	Aggiornamento	D. Boral Capital	Hold → Buy
2025-06-30	Downgrade	D. Boral Capital	Buy → Hold
2025-06-30	Iniziato	H.C. Wainwright	Buy
2025-03-07	Iniziato	Leerink Partners	Outperform
2025-01-13	Iniziato	D. Boral Capital	Buy
2024-08-26	Iniziato	Rodman & Renshaw	Buy
2023-08-10	Iniziato	RBC Capital Mkts	Outperform
2021-02-17	Iniziato	Needham	Buy
2020-09-29	Iniziato	JMP Securities	Mkt Outperform
2020-09-21	Iniziato	Truist	Buy
2019-12-18	Iniziato	B. Riley FBR	Buy
2019-03-26	Reiterato	H.C. Wainwright	Buy
2018-12-06	Iniziato	ROTH Capital	Buy
2017-09-25	Reiterato	H.C. Wainwright	Buy
2017-08-10	Reiterato	Rodman & Renshaw	Buy
2017-05-05	Reiterato	Rodman & Renshaw	Buy
2016-11-11	Reiterato	FBR & Co.	Outperform
2016-03-17	Reiterato	FBR Capital	Outperform
2016-03-03	Iniziato	FBR Capital	Outperform
2015-11-16	Reiterato	ROTH Capital	Neutral
2015-10-29	Reiterato	ROTH Capital	Neutral
2015-05-06	Downgrade	ROTH Capital	Buy → Neutral
2014-12-08	Reiterato	ROTH Capital	Buy
2011-10-03	Downgrade	Maxim Group	Buy → Hold

Mostra tutto

CorMedix Inc Borsa (CRMD) Ultime notizie

07:59 AM

RBC Capital Trims CorMedix Price Target to $13 From $14, Maintains Outperform Rating - marketscreener.com

07:59 AM

Jul 05, 2026

CRMDCorMedix Inc Volatility & Greeks - Finviz

Jul 05, 2026

CRMD Stock Jumps As Antifungal Drug Clears Key Trial For $2B Preventive Market - Stocktwits

Jul 05, 2026

Jul 02, 2026

CRMD News | CORMEDIX INC (NASDAQ:CRMD) - ChartMill

Jul 02, 2026

CorMedix Names Elizabeth Hurlburt as Chief Operating, Commercial Officer - Moomoo

Jul 02, 2026

[8-K] CorMedix Inc. Reports Material Event - Stock Titan

Jul 02, 2026

Lobbying Update: $380,000 of CORMEDIX INC. lobbying was just disclosed - Quiver Quantitative

Jul 02, 2026

Tranche Update on CorMedix Inc.'s Equity Buyback Plan announced on February 2, 2026. - marketscreener.com

Jul 02, 2026

Jul 01, 2026

Liquidity Mapping Around (CRMD) Price Events - Stock Traders Daily

Jul 01, 2026

CRMD,PEP Revenue Breakdown - Finviz

Jul 01, 2026

CORMEDIX INC. Files 8-K: Company Details, Stock Info & SEC Filing Summary for June 25, 2026 - Minichart

Jul 01, 2026

CorMedix (NASDAQ: CRMD) replaces CBIZ with Ernst & Young as auditor - Stock Titan

Jul 01, 2026

Jun 30, 2026

CorMedix Inc.(NasdaqGM:CRMD) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com

Jun 29, 2026

CorMedix Inc.(NasdaqGM: CRMD) dropped from Russell 2500 Growth Benchmark - marketscreener.com

Jun 29, 2026